Cardiovascular and oncological diseases: how to break the vicious circle?

Mortality from cardiovascular and oncological diseases has remained at record highs for many years. Clinicians pay attention to the frequent combination of these two pathologies. Naturally, question arises, what unites seemingly different among themselves? Modern cancer therapy allowed people achieve a cure or stable remission, but same time led appearance cardiac pathology. The relationship between development cardiotoxic events after antitumor been well studied, undeservedly little is allocated in real clinical practice study vasculotoxicity patients. This approach can be considered as earliest predictor damage microvasculature result specific therapy. analysis groups anticancer drugs that cause chronic heart failure vascular endothelium greatest extent was carried out. main approaches risk stratification cardio-oncological patients are considered. principles used prevention treatment cardio- have studied.